Published in J Appl Oral Sci on August 03, 2012
Dental abscess: A microbiological review. Dent Res J (Isfahan) (2013) 0.92
Characterisation of the plasmidome within Enterococcus faecalis isolated from marginal periodontitis patients in Norway. PLoS One (2013) 0.81
Defining genetic fitness determinants and creating genomic resources for an oral pathogen. Appl Environ Microbiol (2017) 0.75
Crystal structure of bis-[1-(2-hy-droxy-eth-yl)-2-methyl-5-nitro-1H-imidazole-κN (3)]silver(I) tetra-fluorido-borate methanol monosolvate. Acta Crystallogr E Crystallogr Commun (2015) 0.75
(1)H NMR-based serum metabolomics reveals erythromycin-induced liver toxicity in albino Wistar rats. J Pharm Bioallied Sci (2017) 0.75
Design, formulation, and physicochemical evaluation of periodontal propolis mucoadhesive gel. Dent Res J (Isfahan) (2017) 0.75
Crystal structure of metronidazolium tetra-chlorido-aurate(III). Acta Crystallogr E Crystallogr Commun (2015) 0.75
Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science (1994) 11.18
Susceptibility of anaerobic bacteria to 23 antimicrobial agents. Antimicrob Agents Chemother (1976) 9.53
Active efflux of tetracycline encoded by four genetically different tetracycline resistance determinants in Escherichia coli. Proc Natl Acad Sci U S A (1980) 8.43
Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants. Antimicrob Agents Chemother (1999) 7.94
Inactivation of antibiotics and the dissemination of resistance genes. Science (1994) 7.89
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat Med (2005) 7.15
Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes. Antimicrob Agents Chemother (1984) 6.81
Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin Infect Dis (2002) 6.03
The TetR family of transcriptional repressors. Microbiol Mol Biol Rev (2005) 6.02
Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction. Antimicrob Agents Chemother (1989) 5.09
marA locus causes decreased expression of OmpF porin in multiple-antibiotic-resistant (Mar) mutants of Escherichia coli. J Bacteriol (1988) 4.97
Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States. Antimicrob Agents Chemother (1990) 4.14
Where will new antibiotics come from? Nat Rev Microbiol (2003) 3.99
Multidrug resistance in bacteria. Annu Rev Biochem (2009) 3.96
Efflux-mediated drug resistance in bacteria. Drugs (2004) 3.90
Bacterial resistance to tetracycline: mechanisms, transfer, and clinical significance. Clin Microbiol Rev (1992) 3.51
Adjunctive benefits of systemic amoxicillin and metronidazole in non-surgical treatment of generalized aggressive periodontitis: a randomized placebo-controlled clinical trial. J Clin Periodontol (2005) 3.47
Streptococcal tetracycline resistance mediated at the level of protein synthesis. J Bacteriol (1986) 3.46
Tetracycline resistance determinants: mechanisms of action, regulation of expression, genetic mobility, and distribution. FEMS Microbiol Rev (1996) 3.29
Dental biofilms: difficult therapeutic targets. Periodontol 2000 (2002) 3.26
Cloning and characterization of a Bacteroides conjugal tetracycline-erythromycin resistance element by using a shuttle cosmid vector. J Bacteriol (1989) 3.25
Expression in Escherichia coli of cryptic tetracycline resistance genes from bacteroides R plasmids. Plasmid (1984) 3.19
Resistance to antibiotics mediated by target alterations. Science (1994) 3.18
Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies. J Clin Pathol (1988) 2.52
Methicillin-resistant staphylococci: genetics and mechanisms of resistance. Antimicrob Agents Chemother (1989) 2.37
New perspectives in tetracycline resistance. Mol Microbiol (1990) 2.14
Biochemical and genetical approaches to the mechanism of action of penicillin. Philos Trans R Soc Lond B Biol Sci (1980) 2.11
A Bacteroides tetracycline resistance gene represents a new class of ribosome protection tetracycline resistance. Antimicrob Agents Chemother (1992) 2.11
Tetracyclines: antibiotic action, uptake, and resistance mechanisms. Arch Microbiol (1996) 1.99
Transmembrane permeability channels across the outer membrane of Haemophilus influenzae type b. J Bacteriol (1985) 1.96
Nucleotide sequence of the tetracycline resistance gene of pTHT15, a thermophilic Bacillus plasmid: comparison with staphylococcal TcR controls. Gene (1985) 1.95
The bacteriology of acute necrotizing ulcerative gingivitis. J Periodontol (1982) 1.88
Purification and characterization of Tet(M), a protein that renders ribosomes resistant to tetracycline. J Biol Chem (1991) 1.87
Metronidazole. A therapeutic review and update. Drugs (1997) 1.87
Occurrence of the Campylobacter resistance gene tetO in Enterococcus and Streptococcus spp. Antimicrob Agents Chemother (1988) 1.83
Relation between lipophilicity and pharmacological behavior of minocycline, doxycycline, tetracycline, and oxytetracycline in dogs. Antimicrob Agents Chemother (1975) 1.76
Detection of tet(M) and tet(O) using the polymerase chain reaction in bacteria isolated from patients with periodontal disease. Oral Microbiol Immunol (1995) 1.76
Amoxicillin and metronidazole as an adjunct to full-mouth scaling and root planing of chronic periodontitis. J Periodontol (2009) 1.75
Energy-dependent efflux mediated by class L (tetL) tetracycline resistance determinant from streptococci. Antimicrob Agents Chemother (1987) 1.72
Outer-membrane permeability of bacteria. Crit Rev Microbiol (1986) 1.70
Ribosomal protection proteins and their mechanism of tetracycline resistance. Antimicrob Agents Chemother (2003) 1.70
Nucleotide sequence analysis of tetracycline resistance gene tetO from Streptococcus mutans DL5. J Bacteriol (1988) 1.68
Characterization of a new class of tetracycline-resistance gene tet(S) in Listeria monocytogenes BM4210. Gene (1993) 1.68
Antimicrobial profiles of periodontal pathogens isolated from periodontitis patients in The Netherlands and Spain. J Clin Periodontol (2005) 1.68
Cloning and nucleotide sequence of a chromosomally encoded tetracycline resistance determinant, tetA(M), from a pathogenic, methicillin-resistant strain of Staphylococcus aureus. Antimicrob Agents Chemother (1990) 1.67
Gene heterogeneity for tetracycline resistance in Staphylococcus spp. Antimicrob Agents Chemother (1990) 1.60
Prevalence of tetracycline resistance genes in oral bacteria. Antimicrob Agents Chemother (2003) 1.59
Evolution and spread of tetracycline resistance determinants. J Antimicrob Chemother (1989) 1.58
Characterization of an oxytetracycline-resistance gene, otrA, of Streptomyces rimosus. Mol Microbiol (1991) 1.58
Antimicrobial resistance in the subgingival microflora in patients with adult periodontitis. A comparison between The Netherlands and Spain. J Clin Periodontol (2000) 1.52
Antibacterial resistance: current problems and possible solutions. Indian J Med Sci (2005) 1.50
Bacteroides fragilis resistant to metronidazole after long-term therapy. Lancet (1978) 1.49
Genetic basis of tetracycline resistance in urogenital bacteria. Antimicrob Agents Chemother (1990) 1.48
A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis. Inflamm Res (1997) 1.46
Nucleotide sequence analysis of two 5-nitroimidazole resistance determinants from Bacteroides strains and of a new insertion sequence upstream of the two genes. Antimicrob Agents Chemother (1994) 1.36
Mode of action of metronidazole on anaerobic bacteria and protozoa. Surgery (1983) 1.34
Tetracycline resistance and TetM in oral anaerobic bacteria and Neisseria perflava-N. sicca. Antimicrob Agents Chemother (1988) 1.34
Antimicrobial therapy in periodontitis: the use of systemic antimicrobials against the subgingival biofilm. J Clin Periodontol (2008) 1.30
A new tetracycline resistance determinant, Tet H, from Pasteurella multocida specifying active efflux of tetracycline. Antimicrob Agents Chemother (1993) 1.30
TetZ, a new tetracycline resistance determinant discovered in gram-positive bacteria, shows high homology to gram-negative regulated efflux systems. Plasmid (2000) 1.29
Metronidazole plus amoxycillin in the treatment of Actinobacillus actinomycetemcomitans associated periodontitis. J Clin Periodontol (1989) 1.28
The mechanism of action of penicillin. Penicillin acylates the active site of Bacillus stearothermophilus D-alanine carboxypeptidase. J Biol Chem (1980) 1.26
The acquisition of antibiotic resistance in the periodontal microflora. Periodontol 2000 (1996) 1.26
Antibiotic resistance in general dental practice--a cause for concern? J Antimicrob Chemother (2004) 1.25
Molecular cloning and functional analysis of a novel tetracycline resistance determinant, tet(V), from Mycobacterium smegmatis. Antimicrob Agents Chemother (1998) 1.24
Comparison of the microbiological features of chronic and aggressive periodontitis. Periodontol 2000 (2010) 1.22
Inhibition of the ribosomal peptidyl transferase reaction by the mycarose moiety of the antibiotics carbomycin, spiramycin and tylosin. J Mol Biol (2000) 1.19
The mechanism of action of penicillin. Sci Prog (1978) 1.19
Prevalence, phenotype and genotype of oral enterococci. Oral Microbiol Immunol (2004) 1.18
Antibiotic resistance in Helicobacter pylori infection. Br Med Bull (1998) 1.17
Detection of conjugal transfer systems in oral, black-pigmented Bacteroides spp. J Bacteriol (1990) 1.17
Plasmids pIP419 and pIP421 from Bacteroides: 5-nitroimidazole resistance genes and their upstream insertion sequence elements. Microbiology (1995) 1.17
Hybridization analysis of the class P tetracycline resistance determinant from the Clostridium perfringens R-plasmid, pCW3. Plasmid (1988) 1.16
Antimicrobial strategies for treatment of periodontal diseases. Periodontol 2000 (1994) 1.15
Genetics of 5-nitroimidazole resistance in Bacteroides species. Anaerobe (1996) 1.14
Tetracycline inhibits propagation of deoxyribonucleic acid replication and alters membrane properties. Antimicrob Agents Chemother (1977) 1.14
Penicillin resistance in the subgingival microbiota associated with adult periodontitis. J Clin Microbiol (1986) 1.13
Quinolone resistance due to reduced target enzyme expression. J Bacteriol (2003) 1.13
Subgingival microflora of periodontal patients on tetracycline therapy. J Clin Periodontol (1979) 1.11
Antibiotic resistance of subgingival species during and after antibiotic therapy. J Clin Periodontol (2002) 1.10
Reduced transcription of the ferredoxin gene in metronidazole-resistant Trichomonas vaginalis. Proc Natl Acad Sci U S A (1992) 1.09
Short-term benefits of the adjunctive use of metronidazole plus amoxicillin in the microbial profile and in the clinical parameters of subjects with generalized aggressive periodontitis. J Clin Periodontol (2010) 1.09
Emergence of mefA and mefE genes in beta-haemolytic streptococci and pneumococci in France. J Antimicrob Chemother (1999) 1.08
Microbiological and clinical results of metronidazole plus amoxicillin therapy in Actinobacillus actinomycetemcomitans-associated periodontitis. J Periodontol (1992) 1.07
Antimicrobial susceptibilities of Porphyromonas gingivalis, Prevotella intermedia, and Prevotella nigrescens spp. isolated in Spain. Antimicrob Agents Chemother (1998) 1.06
Resistant penicillin-binding proteins. Cell Mol Life Sci (1998) 1.05
The efficacy of antimicrobial treatment in Campylobacter pylori-associated gastritis and duodenal ulcer. Scand J Gastroenterol Suppl (1988) 1.05
Detection and incidence of the tetracycline resistance determinant tet(M) in the microflora associated with adult periodontitis. J Periodontol (1995) 1.03
Antibiotic resistance in an in vitro subgingival biofilm model. Oral Microbiol Immunol (2007) 1.03
Clinical and microbiological changes associated with the use of 4 adjunctive systemically administered agents in the treatment of periodontal infections. J Clin Periodontol (1995) 1.03
Isolation of Bacteroides strains with reduced sensitivity to 5-nitroimidazoles. Eur J Clin Microbiol (1986) 1.02
Microbial composition and pattern of antibiotic resistance in subgingival microbial samples from patients with refractory periodontitis. J Periodontol (1993) 1.02
Ribosomal crystallography: peptide bond formation, chaperone assistance and antibiotics activity. Mol Cells (2005) 1.01
Prevalence, proportions, and identities of antibiotic-resistant bacteria in the oral microflora of healthy children. Microb Drug Resist (2003) 1.01
Beta-lactamase production and antimicrobial susceptibility of subgingival bacteria from refractory periodontitis. Oral Microbiol Immunol (2004) 1.00
Periodontal tissue disposition of azithromycin in patients affected by chronic inflammatory periodontal diseases. J Periodontol (1999) 1.00
Antibiotic resistance profile of the subgingival microbiota following systemic or local tetracycline therapy. J Clin Periodontol (2004) 0.99
beta-Lactamase producing bacteria in adult periodontitis. J Clin Periodontol (1997) 0.99
Transferable Tet M in Fusobacterium nucleatum. Antimicrob Agents Chemother (1990) 0.98
Periodontitis and chronic kidney disease: a systematic review of the association of diseases and the effect of periodontal treatment on estimated glomerular filtration rate. J Clin Periodontol (2013) 1.55
Metronidazole alone or with amoxicillin as adjuncts to non-surgical treatment of chronic periodontitis: a 1-year double-blinded, placebo-controlled, randomized clinical trial. J Clin Periodontol (2012) 1.51
Gingival status of Brazilian renal transplant recipients under sirolimus-based regimens. J Periodontol (2008) 1.42
Group B. Initiator paper. Non-surgical periodontal therapy: mechanical debridement, antimicrobial agents and other modalities. J Int Acad Periodontol (2015) 1.40
Prevalence of periodontal pathogens in Brazilians with aggressive or chronic periodontitis. J Clin Periodontol (2005) 1.26
Composition of supra- and subgingival biofilm of subjects with healthy and diseased implants. Clin Oral Implants Res (2008) 1.16
Relationships between subgingival microbiota and GCF biomarkers in generalized aggressive periodontitis. J Clin Periodontol (2010) 1.16
Serum levels of cytokines in subjects with generalized chronic and aggressive periodontitis before and after non-surgical periodontal therapy: a pilot study. J Periodontol (2010) 1.14
Short-term benefits of the adjunctive use of metronidazole plus amoxicillin in the microbial profile and in the clinical parameters of subjects with generalized aggressive periodontitis. J Clin Periodontol (2010) 1.09
In vitro antimicrobial activity of plant extracts and propolis in saliva samples of healthy and periodontally-involved subjects. J Int Acad Periodontol (2005) 1.07
Etiological analysis of initial colonization of periodontal pathogens in oral cavity. J Clin Microbiol (2008) 1.06
Microbiological profile of untreated subjects with localized aggressive periodontitis. J Clin Periodontol (2009) 1.04
Clinical and microbiological benefits of systemic metronidazole and amoxicillin in the treatment of smokers with chronic periodontitis: a randomized placebo-controlled study. J Clin Periodontol (2008) 1.02
Microbial profile on metallic and ceramic bracket materials. Angle Orthod (2002) 0.98
Short-term clinical and microbiological evaluations of peri-implant diseases before and after mechanical anti-infective therapies. Clin Oral Implants Res (2009) 0.97
Prevalence of maxillary sinus septa in 1024 subjects with edentulous upper jaws: a retrospective study. J Oral Implantol (2007) 0.96
Coronally positioned flap for treatment of restored root surfaces: a 6-month clinical evaluation. J Periodontol (2007) 0.94
Human papillomavirus-16 prevalence in gingival tissue and its association with periodontal destruction: a case-control study. J Periodontol (2010) 0.94
Microbiological diversity of peri-implantitis biofilm by Sanger sequencing. Clin Oral Implants Res (2013) 0.94
Prospective study in periodontal maintenance therapy: comparative analysis between academic and private practices. J Periodontol (2011) 0.93
Diversity and quantitative analysis of Archaea in aggressive periodontitis and periodontally healthy subjects. J Clin Periodontol (2011) 0.93
Periodontal risk assessment model in a sample of regular and irregular compliers under maintenance therapy: a 3-year prospective study. J Periodontol (2011) 0.92
Microbiota of the dorsum of the tongue after plaque accumulation: an experimental study in humans. J Periodontol (2006) 0.92
Influence of implant surface topography on early osseointegration: a histological study in human jaws. J Biomed Mater Res B Appl Biomater (2007) 0.92
Early benefits with daily rinsing on gingival health improvements with an essential oil mouthrinse--post-hoc analysis of 5 clinical trials. J Dent Hyg (2014) 0.91
Influence of glycemic control on Epstein-Bar and Cytomegalovirus infection in periodontal pocket of type 2 diabetic subjects. Arch Oral Biol (2010) 0.91
Scaling and root planing and chlorhexidine mouthrinses in the treatment of chronic periodontitis: a randomized, placebo-controlled clinical trial. J Clin Periodontol (2006) 0.91
Oral impact on daily performance, personality traits, and compliance in periodontal maintenance therapy. J Periodontol (2011) 0.91
Influence of obesity and bariatric surgery on the periodontal condition. J Periodontol (2011) 0.90
Quantification of Porphyromonas gingivalis and fimA genotypes in smoker chronic periodontitis. J Clin Periodontol (2009) 0.90
Detection of Actinobacillus actinomycetemcomitans in unstimulated saliva of patients with chronic periodontitis. J Periodontol (2005) 0.90
Local and circulating levels of adipocytokines in obese and normal weight individuals with chronic periodontitis. J Periodontol (2012) 0.90
Local levels of inflammatory mediators in uncontrolled type 2 diabetic subjects with chronic periodontitis. J Clin Periodontol (2013) 0.89
Cytokines and bone-related factors in systemically healthy patients with chronic periodontitis and patients with type 2 diabetes and chronic periodontitis. J Periodontol (2011) 0.89
Current perspective of the impact of smoking on the progression and treatment of periodontitis. Periodontol 2000 (2015) 0.88
Antimicrobial photodynamic therapy in the non-surgical treatment of aggressive periodontitis: microbiological profile. Lasers Med Sci (2011) 0.87
Immunoexpression of angiogenesis, nitric oxide synthase, and proliferation markers in gingival samples of patients with aggressive and chronic periodontitis. J Periodontol (2010) 0.87
Cytokine levels in sites of chronic periodontitis of poorly controlled and well-controlled type 2 diabetic subjects. J Clin Periodontol (2010) 0.87
A microbiological profile of symptomatic teeth with primary endodontic infections. J Endod (2008) 0.87
Clinical and microbiological effects of azithromycin in the treatment of generalized chronic periodontitis: a randomized placebo-controlled clinical trial. J Clin Periodontol (2011) 0.87
Clinical and microbiological benefits of metronidazole alone or with amoxicillin as adjuncts in the treatment of chronic periodontitis: a randomized placebo-controlled clinical trial. J Clin Periodontol (2011) 0.87
Effects of periodontal therapy on GCF cytokines in generalized aggressive periodontitis subjects. J Clin Periodontol (2011) 0.86
Microbial profile of ligature-induced periodontitis in rats. Arch Oral Biol (2009) 0.86
Systemic antibiotics in the treatment of periodontitis. Periodontol 2000 (2015) 0.86
The effectiveness of a preprocedural mouthrinse containing cetylpyridinium chloride in reducing bacteria in the dental office. J Am Dent Assoc (2010) 0.86
The effects of adjunctive metronidazole plus amoxicillin in the treatment of generalized aggressive periodontitis: a 1-year double-blinded, placebo-controlled, randomized clinical trial. J Clin Periodontol (2012) 0.85
FAM5C contributes to aggressive periodontitis. PLoS One (2010) 0.85
Effectiveness of full-mouth and partial-mouth scaling and root planing in treating chronic periodontitis in subjects with type 2 diabetes. J Periodontol (2009) 0.85
Hypertension may affect tooth-supporting alveolar bone quality: a study in rats. J Periodontol (2010) 0.84
Histologic evaluation of early human bone response to different implant surfaces. J Periodontol (2006) 0.84
Occurrence of Aggregatibacter actinomycetemcomitans in Brazilians with chronic periodontitis. Braz Oral Res (2010) 0.84
Metronidazole and amoxicillin as adjuncts to scaling and root planing for the treatment of type 2 diabetic subjects with periodontitis: 1-year outcomes of a randomized placebo-controlled clinical trial. J Clin Periodontol (2014) 0.84
Secreted osteoclastogenic factor of activated T cells (SOFAT), a novel osteoclast activator, in chronic periodontitis. Hum Immunol (2013) 0.83
Effects of two chronic stress models on ligature-induced periodontitis in Wistar rats. Arch Oral Biol (2011) 0.83
Administration of high doses of caffeine increases alveolar bone loss in ligature-induced periodontitis in rats. J Periodontol (2008) 0.83
Experimental alveolitis in rats: microbiological, acute phase response and histometric characterization of delayed alveolar healing. J Appl Oral Sci (2011) 0.83
Association between severity of body mass index and periodontal condition in women. Clin Oral Investig (2011) 0.83
Receptor activator of nuclear factor-kappa B ligand/osteoprotegerin ratio in sites of chronic periodontitis of subjects with poorly and well-controlled type 2 diabetes. J Periodontol (2010) 0.83
Porphyromonas gingivalis is associated with protease-activated receptor-2 upregulation in chronic periodontitis. J Periodontol (2011) 0.83
Clinical and microbiological benefits of strict supragingival plaque control as part of the active phase of periodontal therapy. J Clin Periodontol (2009) 0.82
Full-mouth disinfection as a therapeutic protocol for type-2 diabetic subjects with chronic periodontitis: twelve-month clinical outcomes: a randomized controlled clinical trial. J Clin Periodontol (2013) 0.82
Metronidazole alone or with amoxicillin as adjuncts to non-surgical treatment of chronic periodontitis: a secondary analysis of microbiological results from a randomized clinical trial. J Clin Periodontol (2014) 0.82
Gingival overgrowth in subjects under immunosuppressive regimens based on cyclosporine, tacrolimus, or sirolimus. J Clin Periodontol (2010) 0.82